Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ideaya Biosciences Inc
(NQ:
IDYA
)
39.49
+1.16 (+3.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ideaya Biosciences Inc
< Previous
1
2
3
4
5
Next >
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
September 15, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 15, 2022
Good morning! It's time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning!
Via
InvestorPlace
Arconic, Rhythm Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
September 15, 2022
U.S. stock futures traded higher this morning ahead of several economic reports. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
IDEAYA Shares Jump On Positive Interim Data From Eye Cancer Trial
September 12, 2022
Via
Benzinga
Why IDEAYA Biosciences Shares Plunging Today
August 15, 2022
Via
Benzinga
Recap: IDEAYA Biosciences Q1 Earnings
May 10, 2022
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Ideaya Biosciences Shares Are Falling Sharply During Wednesday's After-Hours Session
September 14, 2022
Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 10.07% to $11.25 during Wednesday's after-hours session. The company announced an $80 million common stock offering.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 14, 2022
Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.
Via
Benzinga
Where IDEAYA Biosciences Stands With Analysts
September 13, 2022
Over the past 3 months, 4 analysts have published their opinion on IDEAYA Biosciences (NASDAQ:IDYA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
Via
Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Via
Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
Via
Benzinga
US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises
September 12, 2022
Pre-open movers
Via
Benzinga
Oracle, JPMorgan And 3 Stocks To Watch Heading Into Monday
September 12, 2022
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Looking Into IDEAYA Biosciences's Return On Capital Employed
September 09, 2022
Benzinga Pro data, IDEAYA Biosciences (NASDAQ:IDYA) reported Q2 sales of $5.85 million. Earnings fell to a loss of $22.06 million, resulting in a 57.4% decrease from last quarter.
Via
Benzinga
IDEAYA Shares Climb As Initial Stage Uveal Melanoma Study Kick-off In Australia
September 06, 2022
IDEAYA Biosciences (NASDAQ: IDYA) has initiated Investigator Sponsored Trial to evaluate darovasertib as monotherapy in neo-adjuvant and adjuvant settings in primary, non-metastatic uveal melanoma (UM)...
Via
Benzinga
IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate
August 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 29, 2022
Via
Benzinga
AppLovin, Unity Software And Some Other Big Losers From Monday
August 16, 2022
U.S. stocks closed higher on Monday, with the Dow Jones gaining around 150 points. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
August 16, 2022
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Via
Benzinga
Gold Drops Over 1%; Viridian Therapeutics Shares Spike Higher
August 15, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones around 170 points on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 15, 2022
Via
Benzinga
Stocks Trim Morning Losses Ahead Of Retail Earnings
August 15, 2022
Investors are eyeing an influx of earnings from the retail sector later in the week.
Via
Talk Markets
Dow Surges Over 100 Points; Crude Oil Falls Sharply
August 15, 2022
U.S. stocks traded turned higher midway through trading, with the Dow Jones gaining more than 100 points on Monday.
Via
Benzinga
U.S. Stocks Edge Lower; NY Empire State Manufacturing Index Drops In August
August 15, 2022
U.S. stocks traded slightly lower this morning, with the Dow Jones dropping around 40 points on Monday.
Via
Benzinga
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
August 15, 2022
Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New...
Via
Benzinga
Recap: IDEAYA Biosciences Q2 Earnings
August 15, 2022
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q2 earnings results on Monday, August 15, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings IDEAYA Biosciences missed...
Via
Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 27, 2022
Via
Benzinga
IDEAYA's Cancer Candidate Shows Early Tumor Modulation
July 27, 2022
Via
Benzinga
Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK
June 28, 2022
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.